Gastroenterology Practice Questions

Q: Pigment gallstones are usually not seen in which of the following conditions?

Clofibrate therapy. The formation of gallstones depends on the composition of bile. Gallstones are broadly classified into **Cholesterol stones** and **Pigment stones** (Black or Brown) [1]. **Why Clofibrate therapy is the correct answer:** Clofibrate (and other fibrates) increases the risk of **cholesterol gallstones**, not pigment stones. Fibrates inhibit the enzyme *cholesterol 7α-hydroxylase*, which reduces bile acid synthesis. Simultaneously, they increase the activity of *HMG-CoA reductase*, leading to increased biliary cholesterol excretion. This results in supersaturation of bile with cholesterol, promoting the formation of cholesterol stones. **Analysis of Incorrect Options:** * **Gilbert’s Syndrome:** This condition involves a deficiency in glucuronosyltransferase, leading to increased levels of unconjugated bilirubin. Chronic hyperbilirubinemia promotes the precipitation of calcium bilirubinate, leading to **black pigment stones**. * **Alcoholic Cirrhosis:** Cirrhosis is a major risk factor for **pigment stones**. The mechanism involves hypersplenism (leading to hemolysis), decreased hepatic synthesis of bile salts, and impaired gallbladder motility. * **Cystic Fibrosis:** Patients with CF often develop **pigment stones** due to bile acid malabsorption in the terminal ileum and increased biliary calcium concentrations. **NEET-PG High-Yield Pearls:** * **Black Pigment Stones:** Associated with chronic hemolysis (e.g., Thalassemia, Hereditary Spherocytosis), Cirrhosis, and Gilbert’s syndrome. They are usually found in the gallbladder. * **Brown Pigment Stones:** Associated with biliary stasis and **infections** (e.g., *E. coli*, *Clonorchis sinensis*) [2]. They often form *de novo* in the bile ducts [2]. * **Risk Factors for Cholesterol Stones (The 4 F's):** Fat, Female, Fertile, Forty. * **Ileal Resection/Disease:** Leads to bile salt malabsorption, predisposing to cholesterol stones.

Q: Child-Turcotte-Pugh classification is used in the assessment of which condition?

Cirrhosis. The **Child-Turcotte-Pugh (CTP) score** is a clinical tool used to assess the prognosis and severity of **Cirrhosis** (chronic liver disease) [1]. It was originally developed to predict surgical mortality in patients with portal hypertension but is now widely used to determine the necessity of liver transplantation and to adjust drug dosages in hepatic impairment. **Why Cirrhosis is Correct:** The CTP score evaluates liver function based on five parameters (3 biochemical and 2 clinical). A high-yield mnemonic to remember these is **"ABCDE"**: * **A**lbumin (Serum) [1] * **B**ilirubin (Total) [1] * **C**oagulation (Prothrombin Time/INR) [1] * **D**istension (Ascites) [1] * **E**ncephalopathy (Hepatic) [1] Patients are categorized into **Class A** (5–6 points; 100% 1-year survival), **Class B** (7–9 points), or **Class C** (10–15 points; 45% 1-year survival). **Why Other Options are Incorrect:** * **Pancreatitis:** Severity is assessed using the **Ranson Criteria**, **APACHE II**, or **BISAP** score. * **Multiple Myeloma:** Staged using the **Durie-Salmon System** or the **International Staging System (ISS)** based on Beta-2 microglobulin and Albumin. * **AIDS:** Monitored via **CD4+ T-cell counts** and **Viral Load** (HIV RNA). **High-Yield Clinical Pearls for NEET-PG:** * **MELD Score (Model for End-Stage Liver Disease):** Uses Creatinine, Bilirubin, and INR. It is currently preferred over CTP for prioritizing liver transplant allocation because it is more objective [1]. * **CTP Limitation:** It includes subjective variables (grading of ascites and encephalopathy), whereas MELD is purely objective [1]. * **Class C** indicates a decompensated state and is a strong indication for liver transplant evaluation.

Q: A 60-year-old patient presents with bright red blood per rectum. The bleeding started abruptly several hours prior to visit. The patient reports lightheadedness when standing up rapidly but denies abdominal pain, cramping, fever, nausea, or vomiting. He has no history of previous bleeding or abdominal pain but has a history of coronary artery disease and takes aspirin. He is afebrile, slightly hypotensive and tachycardic, but hemodynamically stable. Examination reveals decreased skin turgor and dry mucous membranes. There is no abdominal tenderness. Rectal examination is positive for gross blood. What is the most likely diagnosis?

Arteriovenous malformation. ### Explanation The patient presents with **painless, acute, brisk hematochezia** (bright red blood per rectum) and signs of hypovolemia (orthostatic lightheadedness, tachycardia, dry mucous membranes) without abdominal pain. In an elderly patient, the two most common causes of such a presentation are **Diverticulosis** and **Arteriovenous Malformations (AVMs)/Angiodysplasia**. **Why Arteriovenous Malformation is correct:** AVMs are dilated, tortuous submucosal vessels most commonly found in the cecum and right colon of patients over 60 [1]. They typically cause **painless bleeding** that can range from occult to massive hematochezia [1]. The absence of abdominal pain and the patient's age strongly point toward a vascular cause. **Why the other options are incorrect:** * **Diverticulitis:** While diverticulosis causes painless bleeding, diverticulitis involves inflammation/infection and presents with **left lower quadrant pain**, fever, and altered bowel habits; it rarely causes significant bleeding. * **Infectious Colitis:** This typically presents with **fever, abdominal cramps, and diarrhea** (often mucoid or bloody), which are absent here. * **Ischemic Colitis:** This usually presents with the sudden onset of **crampy abdominal pain** followed by bloody diarrhea, often occurring at "watershed" areas (splenic flexure) during episodes of hypotension [2]. The lack of pain makes this unlikely. **Clinical Pearls for NEET-PG:** * **Most common cause of brisk LGIB in elderly:** Diverticulosis (painless). * **Second most common cause:** Angiodysplasia/AVM (painless). * **Heyde’s Syndrome:** The triad of Aortic Stenosis, GI bleeding from angiodysplasia, and acquired von Willebrand deficiency. * **Initial Management:** Hemodynamic stabilization with IV fluids is always the first step before diagnostic colonoscopy.

Q: Cobalamin absorption may be abnormal in all conditions EXCEPT:

Diverticular disease of the colon. **Explanation:** Cobalamin (Vitamin B12) absorption is a complex process requiring multiple physiological steps. The correct answer is **Diverticular disease of the colon** because B12 absorption occurs exclusively in the **terminal ileum**. Colonic pathology does not interfere with the biochemical pathway of B12 uptake. **Why the other options are incorrect:** * **Chronic Pancreatitis:** Pancreatic proteases are essential to degrade **R-binders** (haptocorrin) which are bound to B12 in the stomach. If these enzymes are deficient, B12 remains bound to R-binders and cannot bind to **Intrinsic Factor (IF)**, preventing absorption. * **Achlorhydria:** Gastric acid and pepsin are required to release B12 from dietary proteins [1]. In conditions like atrophic gastritis or long-term PPI use, the inability to "unstick" B12 from food leads to malabsorption [1]. * **Bacterial Overgrowth Syndromes (SIBO):** Excessive bacteria in the small intestine compete for B12 [1]. They "sequester" or metabolize the B12-IF complex before it reaches the ileal receptors, leading to deficiency [1]. **NEET-PG High-Yield Pearls:** 1. **Site of Absorption:** Terminal Ileum (requires Cubilin receptor). 2. **Schilling Test:** Historically used to differentiate causes of B12 malabsorption (though largely replaced by antibody testing and metabolite levels). 3. **Fish Tapeworm:** *Diphyllobothrium latum* is a classic parasite that competes for B12 in the gut. 4. **Metformin:** Long-term use is a common pharmacological cause of B12 deficiency due to interference with calcium-dependent absorption in the ileum.

Q: Which of the following conditions leads to the endoscopic appearance shown in the image?

Gastric antral vascular ectasia. ***Gastric antral vascular ectasia*** - Shows characteristic **"watermelon stomach"** appearance with longitudinal **red stripes** or streaks in the **gastric antrum** on endoscopy. - Associated with **chronic bleeding** and **iron deficiency anemia**, commonly seen in elderly patients with **cirrhosis** or **chronic kidney disease**. *Intestinal lymphangiectasia* - Presents with **white villi** and **dilated lymphatics** giving a **"white shag carpet"** appearance on **small bowel** endoscopy. - Causes **protein-losing enteropathy** with **hypoproteinemia** and **lymphedema**, not the striped gastric pattern shown. *Amoebic colitis* - Shows **flask-shaped ulcers** with **undermined edges** and **yellow-white exudate** in the **colon**. - Associated with **Entamoeba histolytica** infection causing **bloody diarrhea** and **right lower quadrant pain**. *Necrotising enterocolitis* - Characterized by **bowel wall thickening**, **pneumatosis intestinalis**, and **mucosal necrosis** primarily in **premature neonates**. - Shows **ischemic changes** with **black, necrotic tissue** rather than the vascular striped pattern of GAVE.

Q: A 65-year-old male presents with abdominal pain and distension. He reports maroon-colored stools and has a past medical history of cerebrovascular accident and myocardial infarction. What is the most probable diagnosis?

Acute mesenteric ischemia. The clinical presentation of a 65-year-old patient with sudden abdominal pain, distension, and **maroon-colored stools** (hematochezia/melena) in the context of extensive cardiovascular disease (CVA and MI) is a classic description of **Acute Mesenteric Ischemia (AMI)** [1]. **Why Option B is Correct:** AMI is caused by a sudden reduction in intestinal blood flow, most commonly due to an arterial embolism or thrombosis [1]. This patient has significant risk factors (history of MI and CVA), suggesting an underlying pro-thrombotic state or atrial fibrillation, which can lead to an embolic event in the Superior Mesenteric Artery (SMA). Maroon stools indicate mucosal sloughing and infarction of the bowel wall [1]. **Why Other Options are Incorrect:** * **Options A & D (Ulcerative Colitis/Crohn’s Disease):** While IBD can cause abdominal pain and bloody stools, it typically presents in younger patients with a chronic, relapsing history and constitutional symptoms (weight loss, fever), rather than a sudden onset in an elderly patient with vascular risk factors. * **Option C (Irritable Bowel Syndrome):** IBS is a functional disorder characterized by chronic pain and altered bowel habits. It never causes maroon stools or acute abdominal distension and is a diagnosis of exclusion. **High-Yield Clinical Pearls for NEET-PG:** * **Classic Triad:** Severe abdominal pain "out of proportion" to physical examination findings. * **Gold Standard Investigation:** CT Angiography (CTA). * **Early Sign on X-ray:** Usually normal; late sign is *Pneumatosis intestinalis* (gas in the bowel wall). * **Metabolic Hallmark:** Anion gap metabolic acidosis with elevated serum lactate due to tissue ischemia.

Q: A 45-year-old male complains of weakness. He is obese, a type 2 diabetic, and hypertensive. General examination reveals hepatomegaly. Icterus is visible on the sclera, and pale coloration of the skin is present. Which of the following liver diseases can be seen in this patient?

Nonalcoholic fatty liver disease (NAFLD). ### Explanation **1. Why Nonalcoholic Fatty Liver Disease (NAFLD) is Correct:** The patient presents with the classic **Metabolic Syndrome** profile: obesity, Type 2 Diabetes Mellitus (T2DM), and hypertension. NAFLD is considered the hepatic manifestation of metabolic syndrome [1]. The underlying pathophysiology is **insulin resistance**, which leads to increased lipolysis and the accumulation of triglycerides within hepatocytes (steatosis). Hepatomegaly is a common finding due to fat deposition. While NAFLD is often asymptomatic, advanced stages like Non-alcoholic Steatohepatitis (NASH) can present with jaundice (icterus) and fatigue (weakness) as liver function declines [2]. **2. Why Other Options are Incorrect:** * **Alcoholic Fatty Liver Disease (AFLD) & Alcoholic Hepatitis:** While the clinical presentation of AFLD/Alcoholic Hepatitis can be identical to NAFLD/NASH, there is no history of significant alcohol consumption provided in the vignette [2]. In the presence of strong metabolic risk factors (Diabetes, Obesity), NAFLD is the most likely diagnosis unless alcohol abuse is specified. * **All of the Above:** This is incorrect because the patient's specific comorbidities (T2DM and Obesity) point directly toward a metabolic etiology rather than an alcoholic one. **3. Clinical Pearls for NEET-PG:** * **Gold Standard Diagnosis:** Liver biopsy is the gold standard to differentiate simple steatosis from NASH (look for **Mallory-Denk bodies** and **ballooning degeneration**) [3]. * **First-line Investigation:** Ultrasonography is the initial screening tool of choice. * **Association:** NAFLD is now the most common cause of incidental elevation of liver enzymes and a rising cause of Cryptogenic Cirrhosis. * **Management:** Weight loss (7-10%) and Pioglitazone or Vitamin E (in non-diabetic NASH) are high-yield management points.

Q: Sustained virologic response to antiviral therapy (IFN + Ribavirin) in hepatitis C is indicated by which of the following?

Female sex. Sustained Virologic Response (SVR) is defined as the absence of detectable HCV-RNA in the blood 12 to 24 weeks after the completion of antiviral therapy [1]. Achieving SVR is the primary goal of treatment as it signifies a "virologic cure." Several host and viral factors influence the likelihood of achieving SVR when using the traditional regimen of Interferon (IFN) and Ribavirin. Why "Female sex" is correct: Historically, female sex is a well-documented positive predictor of SVR. Women generally show better response rates to interferon-based therapies compared to men. Other favorable host factors include younger age ( 600,000–800,000 IU/mL) is a negative predictor of SVR. Patients with low baseline viral loads respond significantly better to treatment. * B. Cirrhosis: The presence of advanced fibrosis or cirrhosis is a major negative predictor [1]. It reduces the efficacy of the drugs and increases the risk of side effects. * C. Age > 40 years: Increasing age is associated with a decreased response to therapy. Patients younger than 40 years have higher SVR rates. High-Yield Clinical Pearls for NEET-PG: 1. Genotype: The most important viral predictor of SVR. Genotype has no effect on progression of liver disease but does affect response to treatment [1]. Genotypes 2 and 3 have much higher SVR rates (~80%) compared to Genotype 1 (~40-50%) with IFN therapy. 2. IL28B Polymorphism: The CC genotype is the strongest host predictor of a favorable response to IFN-alpha. 3. Current Standard: While this question focuses on IFN + Ribavirin, modern treatment has shifted to Direct-Acting Antivirals (DAAs) (e.g., Sofosbuvir), which achieve SVR rates >95% regardless of most traditional negative predictors.

Question 1

Pigment gallstones are usually not seen in which of the following conditions?

Accepted Answer

Clofibrate therapy

Answer

Gilbert's syndrome

Answer

Alcoholic cirrhosis

Answer

Cystic fibrosis

Question 2

Child-Turcotte-Pugh classification is used in the assessment of which condition?

Accepted Answer

Cirrhosis

Answer

Pancreatitis

Answer

Multiple myeloma

Answer

AIDS

Question 3

A 60-year-old patient presents with bright red blood per rectum. The bleeding started abruptly several hours prior to visit. The patient reports lightheadedness when standing up rapidly but denies abdominal pain, cramping, fever, nausea, or vomiting. He has no history of previous bleeding or abdominal pain but has a history of coronary artery disease and takes aspirin. He is afebrile, slightly hypotensive and tachycardic, but hemodynamically stable. Examination reveals decreased skin turgor and dry mucous membranes. There is no abdominal tenderness. Rectal examination is positive for gross blood. What is the most likely diagnosis?

Accepted Answer

Arteriovenous malformation

Answer

Diverticulitis

Answer

Infectious colitis

Answer

Ischemic colitis

Question 4

Cobalamin absorption may be abnormal in all conditions EXCEPT:

Accepted Answer

Diverticular disease of the colon

Answer

Chronic pancreatitis

Answer

Achlorhydria

Answer

Bacterial overgrowth syndromes

Question 5

A 55-year-old male patient presenting with gastritis symptoms was diagnosed with a gastric ulcer three years ago and underwent partial gastrectomy. He is currently on high-dose omeprazole. A follow-up endoscopy reveals two ulcerative lesions in the gastric mucosa. What is the next step in management?

Accepted Answer

Gastrin level

Answer

H. pylori serology

Answer

Insulin tolerance test

Answer

CT scan

Question 6

Which of the following conditions leads to the endoscopic appearance shown in the image?

Accepted Answer

Gastric antral vascular ectasia

Answer

Intestinal lymphangiectasia

Answer

Amoebic colitis

Answer

Necrotising enterocolitis

Question 7

A 65-year-old male presents with abdominal pain and distension. He reports maroon-colored stools and has a past medical history of cerebrovascular accident and myocardial infarction. What is the most probable diagnosis?

Accepted Answer

Acute mesenteric ischemia

Answer

Ulcerative colitis

Answer

Irritable bowel syndrome

Answer

Crohn's disease

Question 8

A 45-year-old male complains of weakness. He is obese, a type 2 diabetic, and hypertensive. General examination reveals hepatomegaly. Icterus is visible on the sclera, and pale coloration of the skin is present. Which of the following liver diseases can be seen in this patient?

Accepted Answer

Nonalcoholic fatty liver disease (NAFLD)

Answer

Alcoholic hepatitis

Answer

Alcoholic fatty liver disease (AFLD)

Answer

All of the above

Question 9

Which of the following statements about pleural effusion in cirrhosis is FALSE?

Accepted Answer

Pleural fluid to serum LDH ratio is < 0.6

Answer

Pleural fluid protein is < 10 g/L

Answer

Pleural fluid glucose is > 80 mg/dL

Answer

Pleural fluid specific gravity is < 1.012

Question 10

Sustained virologic response to antiviral therapy (IFN + Ribavirin) in hepatitis C is indicated by which of the following?

Accepted Answer

Female sex

Answer

High HCV-RNA

Answer

Cirrhosis

Answer

Age > 40 years

Gastroenterology — MCQs

Gastroenterology — MCQs

On this page

Practice by Chapter

Want unlimited practice?